CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-03 | RAAB MICHAEL President & CEO | Shares withheld for taxes | −150,343 | $1.64 | $247K | 332,303 |
| 2021-08-03 | RAAB MICHAEL President & CEO | Exercise or conversion · Stock Option (Right to Buy) | −267,892 | 0 | ||
| 2021-08-03 | Jacobs Jeffrey W Chief Scientific Officer | Exercise or conversion | +10,000 | $0.54 | $5K | 134,051 |
| 2021-08-03 | Jacobs Jeffrey W Chief Scientific Officer | Shares withheld for taxes | −5,613 | $1.64 | $9K | 128,438 |
| 2021-08-03 | Jacobs Jeffrey W Chief Scientific Officer | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2021-06-16 | Bertrand William C JR Director | Grant or award | +8,891 | 83,549 | ||
| 2021-06-16 | Bertrand William C JR Director | Grant or award · Stock Option (Right to Buy) | +32,765 | 32,765 | ||
| 2021-06-16 | Bazemore Robert B Director | Grant or award · Stock Option (Right to Buy) | +32,765 | 32,765 | ||
| 2021-06-16 | Rodgers Richard J Director | Grant or award | +9,917 | 87,527 | ||
| 2021-06-16 | Rodgers Richard J Director | Grant or award · Stock Option (Right to Buy) | +32,765 | 32,765 | ||
| 2021-06-16 | Cadoret-Manier Onaiza Director | Grant or award · Stock Option (Right to Buy) | +32,765 | 32,765 | ||
| 2021-06-16 | Lundberg Jan M Director | Grant or award | +7,181 | 42,799 | ||
| 2021-06-16 | Lundberg Jan M Director | Grant or award · Stock Option (Right to Buy) | +32,765 | 32,765 | ||
| 2021-06-16 | Block Geoffrey A. Director | Grant or award · Stock Option (Right to Buy) | +32,765 | 32,765 | ||
| 2021-06-16 | MOTT DAVID M Director | Grant or award · Stock Option (Right to Buy) | +32,765 | 32,765 | ||
| 2021-06-15 | Jacobs Jeffrey W Chief Scientific Officer | Exercise or conversion | +7,500 | $0.54 | $4K | 131,551 |
| 2021-06-15 | Jacobs Jeffrey W Chief Scientific Officer | Sale | −7,500 | $7.29 | $55K | 124,051 |
| 2021-06-15 | Jacobs Jeffrey W Chief Scientific Officer | Exercise or conversion · Stock Option (Right to Buy) | −7,500 | 10,000 | ||
| 2021-05-28 | Rosenbaum David P. Chief Development Officer | Sale | −3,062 | $7.22 | $22K | 26,750 |
| 2021-05-20 | Rosenbaum David P. Chief Development Officer | Sale | −612 | $7.09 | $4K | 159,435 |
Page 30 of 38 · 756 trades